F. Mayer
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments
Papers in
- Oncology 15
- Cancer Treatment and Pharmacology 7
- Lung Cancer Research Studies 4
-
- Ovarian cancer diagnosis and treatment 15
- Co-authors
- B. Weber (5 shared papers)Hugues Bourgeois (6 shared papers)D. Paraïso (5 shared papers)Éric Pujade-Lauraine (6 shared papers)M. Combe (4 shared papers)Hubert Orfeuvre (4 shared papers)Bernard Leduc (3 shared papers)D. Lepillé (3 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Anti-Cancer Drugs (3 papers)Annals of Oncology (3 papers)European Journal of Cancer (2 papers)Gynecologic Oncology (2 papers)
- Partner nations
- FranceGermanySwitzerland
In The Last Decade
F. Mayer
32 papers receiving 363 citations
Peers
Comparison fields: 5 of 59
- Reproductive Medicine 201
- Obstetrics and Gynecology 72
- Oncology 131
- Surgery 207
- Pathology and Forensic Medicine 56
Countries citing papers authored by F. Mayer
This map shows the geographic impact of F. Mayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Mayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Mayer more than expected).
Fields of papers citing papers by F. Mayer
This network shows the impact of papers produced by F. Mayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Mayer. The network helps show where F. Mayer may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Mayer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 86 | |
| 2 | 2007 | 67 | |
| 3 | 2012 | 31 | |
| 4 | 1999 | 20 | |
| 5 | Pegylated liposomal doxorubicin and carboplatin in late-relapsing ovarian cancer: a GINECO group phase II trial. | 2009 | 19 |
| 6 | 2000 | 18 | |
| 7 | 2009 | 14 | |
| 8 | 2006 | 12 | |
| 9 | 2004 | 12 | |
| 10 | 2010 | 11 | |
| 11 | 2004 | 11 | |
| 12 | 2005 | 11 | |
| 13 | 1994 | 10 | |
| 14 | 2007 | 6 | |
| 15 | 2009 | 5 | |
| 16 | 1986 | 5 | |
| 17 | 1993 | 5 | |
| 18 | [Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide]. | 1993 | 4 |
| 19 | 2010 | 4 | |
| 20 | 2016 | 4 |
About F. Mayer
F. Mayer is a scholar working on Oncology, Reproductive Medicine, Surgery, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 33 papers that have together received 380 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (15 papers), Intraperitoneal and Appendiceal Malignancies (11 papers), Cancer Treatment and Pharmacology (7 papers), Lung Cancer Research Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers), Endometrial and Cervical Cancer Treatments (3 papers), Testicular diseases and treatments (3 papers) and Chemotherapy-induced organ toxicity mitigation (3 papers). The work is most often cited by research in Reproductive Medicine (201 citations), Obstetrics and Gynecology (72 citations), Oncology (131 citations), Surgery (207 citations) and Pathology and Forensic Medicine (56 citations). F. Mayer has collaborated with scholars based in France, Germany and Switzerland. Frequent co-authors include B. Weber, Hugues Bourgeois, D. Paraïso, Éric Pujade-Lauraine, M. Combe, Hubert Orfeuvre, Bernard Leduc, D. Lepillé, Jean-Marc Ferrero and C. Lhommé. Their work appears in journals such as Journal of Clinical Oncology, Anti-Cancer Drugs, Annals of Oncology, European Journal of Cancer and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.